"Colonoscopy is considered the gold-standard when screening for colorectal cancer," says gastroenterologist Dr. Brian McGee, MD. "It’s a safe procedure that is the only cancer screening tool that can ...

Ulcerative colitis is an inflammatory bowel disease in which the inner lining of the large intestine and rectum become inflamed. It is characterized by diarrhea, abdominal pain and blood in the stool.

Precise polyp segmentation is vitally essential for detection and diagnosis of early colorectal cancer. Recent advances in artificial intelligence have brought infinite possibilities for this task.

We investigated the mechanisms of barrier dysfunction in mild to moderately inflamed Crohn’s disease, and found a decreased expression and redistribution of the sealing claudins 5 and 8 as well as ...

People with Crohn’s disease offer the best advice, tips, and tricks they have for managing inflammatory bowel disease (IBD).

Bhat: I love this question! Crohn’s disease treatment has progressed significantly in recent years, incorporating new mechanisms of action such as interleukin inhibitors and Janus kinase ...

Cartabuke: The biggest challenges in the treatment of Crohn’s disease include managing refractory disease, preventing and treating complications, and addressing the high cost of biologic therapies.

Background: Ustekinumab is used off-label in pediatric Crohn’s disease refractory to anti-tumor necrosis factor. Data on optimal dosing, target trough levels, and potential benefit of therapeutic drug ...

Some complementary therapies can support other conventional treatments for Crohn's disease. Learn which alternative therapies may help.

This study demonstrates that polyp detection in colonoscopy images can be efficiently performed using a combination of depth maps, salient object-extracted maps, and transformers. This graphic ...

Objective The efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is controversial. The aim of this study was to ...

For moderate to severe Crohn's disease, the combination of infliximab plus azathioprine appears to produce higher rates of clinical remission than either agent alone.